Clinical Roundup Targeting Pol 1 could rewire cancer cells and suppress tumor growth, Johns Hopkins study finds June 20, 2025Vol.51 No.24
Drugs & Targets FDA approves Zusduri for intravesical solution in recurrent LG-IR-NMIBC June 20, 2025Vol.51 No.24
Capitol Hill Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheavalSusan Collins: Trump’s 40% cut is “so disturbing” June 13, 2025Vol.51 No.23By Claire Marie Porter
Regulatory News In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.” June 13, 2025Vol.51 No.23By Jacquelyn Cobb
CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosisObservational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy Kennedy: “We’re going to end the war at FDA against alternative medicine” June 13, 2025Vol.51 No.23By Jacquelyn Cobb
In Brief Andrea Califano awarded Stanley P. Reimann Honor Award by Fox Chase June 13, 2025Vol.51 No.23
